Product Images Amlodipine Besylate

Amlodipine Besylate is a tablet available in 10 mg dosage. It comes in a round shape and is packaged in a container of 90 tablets. The ID number is 128 with the NDC number being 70518-0297-01. The lot number is Ref #: 69097-0128-15 and the manufacturer is Cipla USA, Inc. based in Miami, FL 33156. The medication is for prescription only and the package insert should be consulted for directions. The tablets should be kept in a dry place at a temperature of 20-25°C (68-77°F) with excursions to 15-30°C (59-86°F) permitted. These tablets have been repackaged by RemedyRepack Inc. in Indiana, PA 15701.*

Amlodipine Besylate is a prescription medication available in the form of 10 mg round tablets with an arv of 30. The tablets are manufactured by Cipla USA, Inc. and have an NDC# of 70518-0297-02. The lot # is Ref # 69097-0128-15 and the medication expiry date is not available. They should be stored at 20-25°C (68-77°F) with permitted excursions to 15-30°C (59-86°F) [See USP]. The medication is only available on prescription and directions for use can be found on the package insert. The medicine has been repackaged by RemedyRepack Inc. in Indiana, PA with their phone number being 1-724-465-8762.*

Amlodipine Besylate is a tablet with a concentration of 10mg per tablet. The package contains 30 tablets, with a round shape and NDC number 70518-0297-00. The manufacturing company, Cipla USA Inc., is located in Miami, Florida. It is available only with a prescription, and the directions for use are provided in the package insert. It should be stored at a temperature of 20-25°C (68-77°F), with excursions permitted to 15-30°C (59-86°F) [See USP]. The tablet has been repackaged by RemedyRepack Inc. located in Indiana, PA 15701, and their phone number is 1-724-465-8762.*

This is a summary of a study with an event rate, P-value of 0.003, and a hazard ratio of 0.691 with a 95% confidence interval of between 0.54 and 0.88. The study was conducted over a period of 24 months and involves Amlodipine. There is a risk associated with the study, but it is not clear what the risk is.*

This appears to be a table or a chart with data regarding Amlodipine and Placebo for different groups of patients based on age, gender, baseline sitting SBP, baseline vessel disease, and PCI-stent strata. The chart includes the number of patients in each group and potentially some statistical measurements, but it is not possible to interpret the data without the actual numbers represented in the chart.*